HBV-related acute hepatitis due to immune checkpoint inhibitors in a patient with malignant melanoma

dc.contributor.authors	Koksal, AS; Toka, B; Eminler, AT; Hacibekiroglu, I; Uslan, MI; Parlak, E;
dc.date.accessioned	2020-02-27T08:26:38Z
dc.date.available	2020-02-27T08:26:38Z
dc.date.issued	2017
dc.identifier.citation	Koksal, AS; Toka, B; Eminler, AT; Hacibekiroglu, I; Uslan, MI; Parlak, E; (2017). HBV-related acute hepatitis due to immune checkpoint inhibitors in a patient with malignant melanoma. ANNALS OF ONCOLOGY, 28, 3104-3103
dc.identifier.issn	0923-7534
dc.identifier.uri	https://doi.org/10.1093/annonc/mdx502
dc.identifier.uri	https://hdl.handle.net/20.500.12619/65850
dc.language	English
dc.publisher	OXFORD UNIV PRESS
dc.subject	Oncology
dc.title	HBV-related acute hepatitis due to immune checkpoint inhibitors in a patient with malignant melanoma
dc.type	Letter
dc.identifier.volume	28
dc.identifier.startpage	3103
dc.identifier.endpage	3104
dc.contributor.department	Sakarya Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri Bölümü
dc.contributor.saüauthor	Toka, Bilal
dc.contributor.saüauthor	Hacıbekiroğlu, İlhan
dc.contributor.saüauthor	Parlak, Erkan
dc.relation.journal	ANNALS OF ONCOLOGY
dc.identifier.wos	WOS:000418855200032
dc.identifier.doi	10.1093/annonc/mdx502
dc.identifier.eissn	1569-8041
dc.contributor.author	A. S. Koksal
dc.contributor.author	Toka, Bilal
dc.contributor.author	A. T. Eminler
dc.contributor.author	Hacıbekiroğlu, İlhan
dc.contributor.author	M. I. Uslan
dc.contributor.author	Parlak, Erkan